When monitoring a client on albendazole therapy, which lab values should the nurse prioritize?

When a client is on albendazole therapy, it is crucial to prioritize blood urea nitrogen (BUN) and creatinine levels to monitor renal function. Albendazole is metabolized in the liver but excreted primarily through the kidneys. Monitoring these lab values helps assess the client’s kidney function, which is vital since any impairment can affect drug clearance and increase the risk of adverse effects. High levels of BUN and creatinine may indicate renal impairment, which could necessitate dosage adjustments or alternative therapies.

Although other lab values, such as liver function tests or a complete blood count, can also be important in certain contexts, they are not as directly related to the primary concerns surrounding albendazole use. Liver function tests are helpful but typically more relevant in the assessment of drugs with significant hepatic metabolism or toxicity. An electrolyte panel, while valuable in various clinical situations, does not specifically pertain to albendazole therapy in the same way renal function does. Thus, focusing on kidney function through BUN and creatinine is essential for ensuring the safety and efficacy of albendazole treatment.